Funding for this research was provided by:
J. Todd Kuenstner (1)
Text and Data Mining valid from 2019-06-20
Received: 13 March 2019
Accepted: 30 May 2019
First Online: 20 June 2019
Ethics approval and consent to participate
: This study conforms to the principles outlined in the Declaration of Helsinki. The goals of the study were explained to all of the participants and signed informed consent forms were obtained from all study subjects.
: All authors agree to the terms of the BioMed Central Copyright Manuscript and License Agreement and consent to the publication of this article.
: Kuenstner is a shareholder of AVIcure Bioscience, a company with proprietary interests in Ultraviolet blood irradiation (UVBI) therapy. Kali and Welch have no competing interests.